These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28199208)
21. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer. Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608 [TBL] [Abstract][Full Text] [Related]
22. Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells. Cheon SK; Kim HP; Park YL; Jang JE; Lim Y; Song SH; Han SW; Kim TY Mol Oncol; 2018 Aug; 12(8):1398-1409. PubMed ID: 29896883 [TBL] [Abstract][Full Text] [Related]
23. [Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia]. Xie XF; Zhan Y; Ye YH; Li C; Zhang Y Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):278-82. PubMed ID: 20646540 [TBL] [Abstract][Full Text] [Related]
24. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer. He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396 [TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer]. Wu HM; Zhu SL; He LJ; Liu YH; Xie D Ai Zheng; 2009 Oct; 28(10):1054-60. PubMed ID: 19799813 [TBL] [Abstract][Full Text] [Related]
27. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma. Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292 [TBL] [Abstract][Full Text] [Related]
28. MIF and D-DT are potential disease severity modifiers in male MS subjects. Benedek G; Meza-Romero R; Jordan K; Zhang Y; Nguyen H; Kent G; Li J; Siu E; Frazer J; Piecychna M; Du X; Sreih A; Leng L; Wiedrick J; Caillier SJ; Offner H; Oksenberg JR; Yadav V; Bourdette D; Bucala R; Vandenbark AA Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8421-E8429. PubMed ID: 28923927 [TBL] [Abstract][Full Text] [Related]
29. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer. Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415 [TBL] [Abstract][Full Text] [Related]
30. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas. Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. Meyer-Siegler KL; Iczkowski KA; Leng L; Bucala R; Vera PL J Immunol; 2006 Dec; 177(12):8730-9. PubMed ID: 17142775 [TBL] [Abstract][Full Text] [Related]
32. Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor. Xia W; Xie C; Jiang M; Hou M Mol Cell Biochem; 2015 Jun; 404(1-2):11-24. PubMed ID: 25701358 [TBL] [Abstract][Full Text] [Related]
33. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Heinrichs D; Knauel M; Offermanns C; Berres ML; Nellen A; Leng L; Schmitz P; Bucala R; Trautwein C; Weber C; Bernhagen J; Wasmuth HE Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17444-9. PubMed ID: 21969590 [TBL] [Abstract][Full Text] [Related]
34. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702 [TBL] [Abstract][Full Text] [Related]
35. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer. Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658 [TBL] [Abstract][Full Text] [Related]
36. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death. Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533 [TBL] [Abstract][Full Text] [Related]
37. Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas. Cuthbert RJ; Wilson JM; Scott N; Coletta PL; Hull MA Eur J Cancer; 2009 Jun; 45(9):1654-63. PubMed ID: 19269807 [TBL] [Abstract][Full Text] [Related]
38. Oxymatrine Inhibits Homocysteine-Mediated Autophagy via MIF/mTOR Signaling in Human Umbilical Vein Endothelial Cells. Zhang Y; Zhang Y; Tang J; Zhao S; Li C; Huang YP; Yi M Cell Physiol Biochem; 2018; 45(5):1893-1903. PubMed ID: 29510402 [TBL] [Abstract][Full Text] [Related]